There are three common ways to a peptide.
They differ in what you know about the product, who is responsible, and what it costs. Open the one that's you.
Not sure which way is yours? Answer three things and we'll email the checked options for your country — free.
Get my shortlist- Medicine
Prescribed, from a pharmacy
It exists as an approved medicine.
- You know
- Everything — dose, purity, stability
- Responsible
- Manufacturer, pharmacist, regulator
- Cost
- Highest, but falling fast
GMP · FDA / EMAThis is me - Compounding pharmacy
Prescribed, made for you
You want a personalised or cheaper prescription route.
- You know
- Most of it — made to a published standard
- Responsible
- The licensed pharmacy
- Cost
- Middle, often cheaper
GMP · USP <797>This is me - Research-use-only
Buying a research chemical
It isn't approved anywhere yet.
- You know
- Only what the seller claims
- Responsible
- You
- Cost
- Lowest — you carry the risk
Nothing — run the CheckThis is me
Two ways are covered. One isn't.
Ways 1 and 2 sit under GMP: Good Manufacturing Practice. A legally enforced manufacturing standard. Production is inspected, every batch is documented and release-tested, and a failed batch can be recalled. It is the reason the dose on the label is the dose in the vial. — someone already assured the quality. Way 3 is the only one where nobody did.
Swipe the table sideways →
| What you get | Way 1Medicine | Way 2Compounding pharmacy | Way 3Research-use-only |
|---|---|---|---|
| Prescription needed | Yes | Yes | No |
| Made under GMP | Yes | Yes | No |
| Dose in the vial is known | Yes | Yes | No |
| Purity documented for you | Yes | Yes | Sometimes |
| Shipping stability engineered | Yes | Yes | No |
| Someone accountable if it's wrong | Yes | Yes | No |
| Needs a Check before you buy | No | Licence only | Yes |
What already covers these ways
Inspected production, batch records, release testing.
Documented processes, audited by a third party.
The standard a purity result should be produced under.
Approval, labelling and recall systems stand behind the product.
How a pharmacy must prepare an injectable for a patient.
Standards that apply to approved medicines and licensed compounding pharmacies. MyDosage does not issue or audit them — we point at who does.
The same peptide, three prices.
Typical monthly cost, the oversight you get for it, and how long you wait. Native currency only — we never convert.
Peptide and GLP-1 costs in United States
| The way | Typical cost (US) | Oversight you get | Prescription | Typical wait |
|---|---|---|---|---|
| Way 1 · Approved medicineAvailable | $149–$1,350/month | Regulator + pharmacist. Recall system behind every batch. | Required | Same week — often same day via telehealth |
| Way 2 · Compounding pharmacyAvailable | $199–$499/month | Pharmacy licence + sterile-preparation standard. No approval trial. | Required | 3–10 days after the consult |
| Way 3 · Lab supplier (RUO)Available | $30–$180/month | None. Nobody verified the vial for you — run the Check. | None | 3–21 days, customs dependent |
Insurance sometimes covers it — check your plan and the manufacturer's savings program before paying cash.
| Medicine | Substance | Price (US) | Note |
|---|---|---|---|
| Wegovy | Semaglutide | $349–$499/month | Manufacturer cash-pay pricing in the US; private prescription elsewhere. |
| Ozempic | Semaglutide | $499–$999/month | Licensed for type 2 diabetes; weight-loss use is off-label. |
| Zepbound | Tirzepatide | $349–$550/month | UK/EU sold as Mounjaro for weight management. |
| Mounjaro | Tirzepatide | $500–$1,080/month | — |
| Rybelsus | Oral semaglutide | $149–$399/month | The cheapest approved entry point in the US today. |
| Saxenda | Liraglutide | $349–$550/month | — |
Peptide and GLP-1 costs in United Kingdom
| The way | Typical cost (UK) | Oversight you get | Prescription | Typical wait |
|---|---|---|---|---|
| Way 1 · Approved medicineAvailable | £129–£260/month | Regulator + pharmacist. Recall system behind every batch. | Required | Same week — often same day via telehealth |
| Way 2 · Compounding pharmacyLimited | £150–£320/month | Pharmacy licence + sterile-preparation standard. No approval trial. | Required | 3–10 days after the consult |
| Way 3 · Lab supplier (RUO)Available | £30–£160/month | None. Nobody verified the vial for you — run the Check. | None | 3–21 days, customs dependent |
An NHS route exists with strict criteria; private prescription prices are what we show here.
| Medicine | Substance | Price (UK) | Note |
|---|---|---|---|
| Wegovy | Semaglutide | £129–£199/month | Manufacturer cash-pay pricing in the US; private prescription elsewhere. |
| Ozempic | Semaglutide | £150–£220/month | Licensed for type 2 diabetes; weight-loss use is off-label. |
| Zepbound | Tirzepatide | £180–£260/month | UK/EU sold as Mounjaro for weight management. |
| Mounjaro | Tirzepatide | £150–£250/month | — |
| Rybelsus | Oral semaglutide | £140–£210/month | The cheapest approved entry point in the US today. |
| Saxenda | Liraglutide | £130–£190/month | — |
Peptide and GLP-1 costs in European Union
| The way | Typical cost (EU) | Oversight you get | Prescription | Typical wait |
|---|---|---|---|---|
| Way 1 · Approved medicineAvailable | €140–€300/month | Regulator + pharmacist. Recall system behind every batch. | Required | Same week — often same day via telehealth |
| Way 2 · Compounding pharmacyLimited | €160–€350/month | Pharmacy licence + sterile-preparation standard. No approval trial. | Required | 3–10 days after the consult |
| Way 3 · Lab supplier (RUO)Available | €30–€170/month | None. Nobody verified the vial for you — run the Check. | None | 3–21 days, customs dependent |
Mostly self-pay. Reimbursement exists in a few countries for specific diagnoses only.
| Medicine | Substance | Price (EU) | Note |
|---|---|---|---|
| Wegovy | Semaglutide | €150–€270/month | Manufacturer cash-pay pricing in the US; private prescription elsewhere. |
| Ozempic | Semaglutide | €130–€250/month | Licensed for type 2 diabetes; weight-loss use is off-label. |
| Zepbound | Tirzepatide | €200–€300/month | UK/EU sold as Mounjaro for weight management. |
| Mounjaro | Tirzepatide | €180–€300/month | — |
| Rybelsus | Oral semaglutide | €140–€230/month | The cheapest approved entry point in the US today. |
| Saxenda | Liraglutide | €130–€200/month | — |
Peptide and GLP-1 costs in Rest of world
| The way | Typical cost (Rest of world) | Oversight you get | Prescription | Typical wait |
|---|---|---|---|---|
| Way 1 · Approved medicineLimited | Not published | Regulator + pharmacist. Recall system behind every batch. | Required | Same week — often same day via telehealth |
| Way 2 · Compounding pharmacyNot available | Not published | Pharmacy licence + sterile-preparation standard. No approval trial. | Required | 3–10 days after the consult |
| Way 3 · Lab supplier (RUO)Available | 30–200 USD/month | None. Nobody verified the vial for you — run the Check. | None | 3–21 days, customs dependent |
We don't publish prices we haven't checked in your country yet.
| Medicine | Substance | Price (Rest of world) | Note |
|---|---|---|---|
| Wegovy | Semaglutide | Not published | Manufacturer cash-pay pricing in the US; private prescription elsewhere. |
| Ozempic | Semaglutide | Not published | Licensed for type 2 diabetes; weight-loss use is off-label. |
| Zepbound | Tirzepatide | Not published | UK/EU sold as Mounjaro for weight management. |
| Mounjaro | Tirzepatide | Not published | — |
| Rybelsus | Oral semaglutide | Not published | The cheapest approved entry point in the US today. |
| Saxenda | Liraglutide | Not published | — |
Prices checked 1 September 2026 · list and cash prices, not insurance-adjusted
Prices move, and what you actually pay depends on your country and your insurance. Ask us for the current numbers for your country — free, and we send them with the checked options.
“It exists as an approved medicine.”
Prescribed, from a pharmacy
A doctor writes a prescription; a pharmacy hands you an approved product like Ozempic, Wegovy, Mounjaro, Zepbound, or one of the new oral GLP-1s.
What you get
A product tested in trials on thousands of people. The dose in the pen is the dose on the label. Stability and storage are engineered and printed on the box. The guidelines are exact, a pharmacist is accountable, and if a batch is wrong there is a recall system. Very little can silently go wrong before it reaches you.
The honest downsides
You need a prescription, insurance may not cover it, and it can be expensive — though this is changing fast: oral GLP-1s now start around $149/month in the US, and more approvals are coming.
We're loading what we've checked where you are.
- A shortlist matched to where you live
- What a consultation and the medicine actually cost
- Free — and it saves you the comparing
Who makes the approved products
“You want a personalised or cheaper prescription route.”
Prescribed, made for you
You visit a clinic (often online), get a prescription, and a licensed Compounding: A pharmacy preparing a specific formulation for one patient. A licensed pharmacy mixes a prescription to order — a specific dose, strength or combination. It still happens under GMP conditions in an inspected facility, against a published sterile-preparation standard. pharmacy prepares that specific formulation for you.
What you get
Honestly, mostly the same thing under a different name — and sometimes cheaper. It can be more personalised if you need specific doses or combinations. It is still made under GMP: Good Manufacturing Practice. A legally enforced manufacturing standard. Production is inspected, every batch is documented and release-tested, and a failed batch can be recalled. It is the reason the dose on the label is the dose in the vial. conditions by a licensed, inspected pharmacy that must compound sterile injectables to USP <797>: The sterile compounding standard. The published United States Pharmacopeia chapter that sets how a pharmacy must prepare an injectable: air quality, testing, beyond-use dating and staff training.: tested, regulated, accountable.
The honest downsides
It is still a prescription route, and this layer is legally in motion — what compounders may produce (especially GLP-1s) has been restricted recently and varies over time and by region. Which specific pharmacy is behind your clinic matters. Licensed status is checkable, and we check it.
We're loading what we've checked where you are.
- Pharmacies matched to your state, with the clinic that can prescribe
- Whether it's a 503A pharmacy or a 503B facility — and why that matters
- Free — and every licence link is included
What covers a pharmacy
Inspected production, batch records, release testing.
Documented processes, audited by a third party.
How a pharmacy must prepare an injectable for a patient.
A licensed pharmacy is inspected and must compound sterile injectables to a published standard. That licence is public, and it is what we check here — not a supplier trust score.
“It isn't approved anywhere yet.”
Buying a research chemical
Lab-supply companies sell peptides labelled RUO: Research use only. A label stating the product is sold for laboratory research, not for people. No prescription, no pharmacy and no approval sit behind it, so nobody has verified the contents, the stability or the handling for you.. No prescription, no pharmacy, no approval.
What actually happens here
The seller states the product is for research. When a person uses it on themselves anyway, the responsibility shifts to them. Nobody has verified what's in the vial for you, nobody engineered its shipping stability for you, and no system stands behind you if something is wrong. That's the deal, and you should make it with open eyes.
Where this way is genuinely the only one
Peptides that aren't on the market yet. Retatrutide is the clearest example — developed by Eli Lilly, still in trials, not approved anywhere, yet sold today as a research chemical. The same goes for most healing and longevity peptides, which may never go through approval at all. If you choose this way, the entire burden of judging the supplier falls on you.
Don't compare it all yourself. We'll send what we've checked.
Pick the way you want and tell us where you are. You get the checked options for your country, what they actually cost, and nothing else — no charge, no sales call, one click to unsubscribe.
Way 3 is the reason the Check exists.
Paste a shop link, a brand name, or a certificate, and we assess the whole operation — not just the paperwork: whether a real, registered business is behind it and whether anyone answers; the domain's age and its lookalikes; the web and social footprint; the COA: Certificate of analysis. A lab document stating what a batch contains and at what purity. It is only as good as the issuer: a real COA names the testing lab, the identity of the substance and the amount found, and it matches the batch you were shipped. (are they internally consistent, does the issuer exist, do they state identity and amount); and what the brand publishes about storage and shipping, because a real product handled badly can still degrade on the way to you. You get one plain-language report of everything we could and couldn't confirm.
findings, never accusationsCheck before you buy
Paste the shop link. We'll tell you what we can see.
Who is actually behind the site, how the storefront reads, what the certificate really reports, and what they publish about handling. Free, no account. Where we can't see, we say so.
A check is what we could observe — not a lab test, not a certification, and never a statement about the people behind a business.
MyDosage is information, not medical advice. Talk to a clinician before changing anything you take.